Patent Assignment
Reel/Frame 032111/0430
Assignment of Assignor's Interest
Recorded: 2014-01-21
Pages: 30
Assignors
GLASS, LAWRENCE IRWIN
Executed: 2013-12-11
BICKERDIKE, MICHAEL JOHN
Executed: 2012-11-21
SNAPE, MICHAEL FREDERICK
Executed: 2013-11-21
DE COGRAM, PATRICIA PEREZ
Executed: 2014-01-20
Assignee
NEUREN PHARMACEUTICALS LIMITED
697 BURKE ROAD, SUITE 201, CAMBERWELL, V1C 3124, AUSTRALIA
Covered Property
(1)
Treatment of Autism Spectrum Disorders Using Glycyl-L-2-Methyl Prolyl Glutamic Acid
Application:
61/730,829 →
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Address
Jan 21, 2014
From: NEUREN PHARMACEUTICALS LIMITED
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 032111/0850 →
Assignment of Assignor's Interest
Jul 31, 2015
From: GLASS, LAWRENCE IRWIN; BICKERDIKE, MICHAEL JOHN; SNAPE, MICHAEL FREDERICK; DE COGRAM, PATRICIA PEREZ
To: NEUREN PHARMACEUTICALS LIMITED
Reel/Frame 036242/0306 →